|
The pharmaceutical industry in the investment community has the never fading sunrise industry \As we all know , in 2005 and 2006 , the policy adjustment in China 's pharmaceutical industry , rectify and to combat commercial bribery , the pharmaceutical industry has plunged into an unprecedented low . 2007 , with the government to deepen the reform of the health care system (referred to as health care reform ) series of policy implementation , the pharmaceutical industry has finally started to wake up from a deep sleep , and gradually recovered , entered a new fast track of development . Medical reform , the pharmaceutical industry is the most important catalyst \Our best pharmaceutical companies are concentrated in a listed company , the feast of medical reform will mainly be shared by the listed companies . Pharmaceutical manufacturing listed companies will also become the focus of attention of many investors and stakeholders , then , correct , comprehensive and fair evaluation of the financial results of listed companies in pharmaceutical manufacturing , for investors , creditors , and the management , employees , consumers , suppliers and other stakeholders who have a very important guiding significance . Firstly, research and analysis of the literature on performance evaluation of domestic and foreign enterprises and listed companies , and on this basis , combined with the purpose of this research , to build a set of evaluation of China 's pharmaceutical manufacturing listed companies' financial performance evaluation index system . The system from the short-term solvency , operational capabilities , and long-term solvency , profitability , risk level , shareholder profitability , cash flow capacity , development capacity and eight of 15 indicators reflect China 's pharmaceutical manufacturing listed companies the level of financial results . Indicators data and applications from 2004 to 2007 , a comprehensive evaluation using factor analysis obtained for each of the specific evaluation score and ranking , and horizontal and vertical , macro -and micro- comparative analysis . The innovation of this paper are: summary of the literature on the basis of existing research results , the criterion of the pros and cons of the indicators of dynamic screening methods as well as data preprocessing methods and applications of correspondence analysis for longitudinal comparisons .
|